Many clinical factors were tested for their impact on achieving tumor regression such as sex, age, body mass index (BMI), serum tumor markers CEA, CA72-4, CA19-9, AFP, tumor location, tumor differentiation, tumor Borrmann type, clinical T classification, clinical N classification and administration approach to NAC. The gene discussed is AFP; the disease is neoplasm.